Latest Safety News

X2M Connect has teamed up with Mawson Business Advisory to roll out an integrated AI-driven smart community platform featuring private 5G connectivity, targeting Australia's $6.2 billion retirement village market with long-term contracts.

Aquirian Limited has secured $8 million through a strongly supported placement to accelerate growth of its Drillforce business and support a major $48 million contract at the Lord Byron mine.

Amplia Therapeutics and ANZGOG have initiated a clinical trial to test narmafotinib combined with chemotherapy in ovarian cancer patients unresponsive to platinum-based treatment, aiming to improve surgical outcomes and explore biomarker insights.

Swift TV has gained final Netflix approval after a multi-year certification, becoming Australia’s sole enterprise Connective TV platform with direct Google Play Store access. This integration bolsters its foothold in sectors demanding seamless consumer streaming with robust enterprise controls.

EcoGraf has partnered with NMB Bank to manage compensation payments for communities affected by its Epanko Graphite Project, marking a key step in early works on the Mine Access Road ahead of construction.

BPH Global inks binding deal with Temasek Innovation Holdings to validate its seaweed-based male vitality product through targeted biological assays, advancing regulatory and commercial ambitions.

InteliCare has secured A$2.05 million through a placement to back its commercial expansion following major aged care contracts and initial retirement village deployments.

NRW Holdings’ subsidiary has won a $200 million contract to upgrade Tonkin Highway in Perth, enhancing safety and easing congestion on a key transport corridor. Construction is set to begin in late 2026 with potential for additional works at Hale Road.

Boom Logistics has upgraded its FY26 earnings guidance, anticipating a 31% rise in statutory EPS, backed by $7 million in new contracts across energy and mining sectors.

PYC Therapeutics has dosed the first patient in its Phase 1b trial of PYC-003, targeting Polycystic Kidney Disease, aiming to establish safety and efficacy markers ahead of registrational studies.

ARN Media reported a 10% revenue decline in FY25 but accelerated digital growth and cost savings, while defending ongoing legal disputes with former talent.

Orica Limited posted its strongest half-year EBIT in over 20 years at $512 million, driven by premium product demand and strategic acquisitions including Nelson Brothers. The company also initiated a $100 million cost reduction program and declared a 28.5 cent interim dividend.